CICON24 opens conference registration

Presented by the Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI), CICON continues to be the most important forum for basic and translational research in cancer immunology and immunotherapy.

This year’s meeting will include nine sessions, including more than 30 plenary lectures, and 20+ proffered talks selected from among the submitted abstracts. These exciting sessions will cover the future of the field of cancer immunology, including neoadjuvant and platform trials, multiomic data analysis, tertiary lymphoid aggregates as regulators of anti-cancer immunity, immune health and inflammation, metabolism, the microbiome, personalized therapies, and much more.

To register, and for more information, please go to www.cancerimmunotherapyconference.org/